Finally, BCR and TLR are thought to be key activation pathways in marginal zone lymphoma (MZL), often associated with chronic inflammation in the context of autoimmunity and/or infection [182], implicating BTK as a potential target. The gene discussed is BCR; the disease is marginal zone lymphoma.